| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 92587 |
|
33,999 |
33,948 |
$470K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
22,492 |
22,228 |
$353K |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
32,969 |
32,942 |
$266K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
27,483 |
25,493 |
$246K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
6,227 |
6,209 |
$141K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
10,246 |
10,164 |
$129K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
32,662 |
29,870 |
$108K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
11,281 |
11,268 |
$91K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
10,684 |
10,675 |
$88K |
| G0270 |
Medical nutrition therapy; reassessment and subsequent intervention(s) following second referral in same year for change in diagnosis, medical condition or treatment regimen (including additional hours needed for renal disease), individual, face to face with the patient, each 15 minutes |
46,216 |
44,943 |
$77K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
9,976 |
9,627 |
$70K |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
24,362 |
24,334 |
$65K |
| 0001A |
|
1,399 |
1,393 |
$54K |
| 99177 |
|
29,624 |
29,578 |
$50K |
| 0002A |
|
1,313 |
1,312 |
$49K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
5,686 |
5,051 |
$49K |
| 90620 |
|
3,741 |
3,728 |
$40K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
5,068 |
5,057 |
$35K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
12,448 |
11,657 |
$35K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
7,198 |
7,137 |
$27K |
| 97802 |
|
20,142 |
20,113 |
$24K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
13,441 |
13,431 |
$20K |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
14,373 |
14,356 |
$19K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,124 |
2,093 |
$18K |
| 0071A |
|
535 |
532 |
$18K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,562 |
1,508 |
$17K |
| S9451 |
Exercise classes, non-physician provider, per session |
28,943 |
28,886 |
$17K |
| 83015 |
|
11,246 |
11,189 |
$16K |
| 0072A |
|
399 |
398 |
$15K |
| 86580 |
|
1,968 |
1,953 |
$13K |
| H0001 |
Alcohol and/or drug assessment |
16,353 |
16,332 |
$12K |
| 36415 |
Collection of venous blood by venipuncture |
37,963 |
37,545 |
$11K |
| 87631 |
|
1,476 |
1,476 |
$11K |
| 90686 |
|
15,497 |
15,468 |
$10K |
| 0011A |
|
229 |
229 |
$9K |
| 0003A |
|
237 |
236 |
$9K |
| 0012A |
|
208 |
208 |
$8K |
| 99173 |
|
1,365 |
1,361 |
$6K |
| 36406 |
|
2,270 |
2,249 |
$5K |
| 86480 |
|
1,244 |
1,244 |
$5K |
| 90651 |
|
3,818 |
3,811 |
$5K |
| 90670 |
|
2,343 |
2,332 |
$5K |
| 91307 |
|
1,070 |
995 |
$5K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
575 |
575 |
$4K |
| 85018 |
|
2,218 |
2,210 |
$4K |
| 90734 |
|
3,139 |
3,135 |
$3K |
| 0013A |
|
77 |
77 |
$3K |
| 90716 |
|
978 |
976 |
$3K |
| 0124A |
|
59 |
59 |
$2K |
| 94070 |
|
113 |
111 |
$2K |
| 90707 |
|
824 |
821 |
$2K |
| 3074F |
|
7,786 |
7,777 |
$2K |
| 36410 |
|
1,671 |
1,633 |
$1K |
| 90633 |
|
2,894 |
2,881 |
$1K |
| D1206 |
Topical application of fluoride varnish |
96 |
95 |
$1K |
| 99383 |
|
114 |
114 |
$1K |
| 0154A |
|
29 |
29 |
$1K |
| H0002 |
Behavioral health screening to determine eligibility for admission to treatment program |
16,093 |
16,076 |
$1K |
| 90672 |
|
433 |
432 |
$921.18 |
| 90744 |
|
2,057 |
2,052 |
$853.13 |
| 90715 |
|
1,367 |
1,366 |
$838.38 |
| 99381 |
|
125 |
124 |
$803.72 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
100 |
98 |
$798.78 |
| 90723 |
|
1,426 |
1,422 |
$755.00 |
| 90685 |
|
572 |
568 |
$537.93 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
131 |
130 |
$507.19 |
| 3079F |
|
1,821 |
1,818 |
$460.00 |
| 91308 |
|
13 |
12 |
$450.02 |
| 90634 |
|
358 |
357 |
$442.49 |
| 99382 |
|
13 |
13 |
$283.59 |
| 87081 |
|
1,377 |
1,364 |
$272.89 |
| 90671 |
|
909 |
907 |
$246.20 |
| 36416 |
|
563 |
561 |
$210.00 |
| 90700 |
|
521 |
520 |
$115.00 |
| 90661 |
|
887 |
887 |
$114.43 |
| G0438 |
Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit |
27 |
27 |
$105.35 |
| 91300 |
|
2,716 |
2,500 |
$104.00 |
| 99384 |
|
39 |
39 |
$99.65 |
| 90680 |
|
1,785 |
1,779 |
$75.00 |
| A7016 |
Dome and mouthpiece, used with small volume ultrasonic nebulizer |
109 |
107 |
$58.26 |
| A7003 |
Administration set, with small volume nonfiltered pneumatic nebulizer, disposable |
110 |
108 |
$54.39 |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
142 |
140 |
$30.00 |
| 94760 |
|
100 |
98 |
$16.86 |
| 90648 |
|
2,152 |
2,148 |
$11.00 |
| J7614 |
Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg |
97 |
95 |
$4.75 |
| G9275 |
Documentation that patient is a current non-tobacco user |
14,032 |
14,014 |
$0.70 |
| G9622 |
Patient not identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method |
15,864 |
15,848 |
$0.52 |
| 91301 |
|
405 |
394 |
$0.48 |
| G9273 |
Blood pressure has a systolic value of < 140 and a diastolic value of < 90 |
4,633 |
4,625 |
$0.00 |
| 1036F |
|
11,552 |
11,537 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
13,432 |
13,412 |
$0.00 |
| G8418 |
Bmi is documented below normal parameters and a follow-up plan is documented |
1,526 |
1,524 |
$0.00 |
| 90696 |
|
718 |
717 |
$0.00 |
| 3008F |
|
1,458 |
1,456 |
$0.00 |
| 1000F |
|
213 |
213 |
$0.00 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
167 |
165 |
$0.00 |
| G9228 |
Chlamydia, gonorrhea and syphilis screening results documented (report when results are present for all of the 3 screenings) |
654 |
654 |
$0.00 |
| 90697 |
|
131 |
131 |
$0.00 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
12 |
12 |
$0.00 |
| 90619 |
|
13 |
13 |
$0.00 |
| 90698 |
|
13 |
13 |
$0.00 |
| 3725F |
|
11,582 |
11,572 |
$0.00 |
| 3016F |
|
11,540 |
11,524 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
10,476 |
10,463 |
$0.00 |
| 90710 |
|
825 |
824 |
$0.00 |
| 1160F |
|
2,099 |
1,945 |
$0.00 |
| 3210F |
|
548 |
541 |
$0.00 |
| G9820 |
Documentation of a chlamydia screening test with proper follow-up |
351 |
351 |
$0.00 |
| 99499 |
|
63 |
62 |
$0.00 |
| 90713 |
|
13 |
13 |
$0.00 |
| 90681 |
|
92 |
92 |
$0.00 |